Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CureVac N.V. stock logo
CVAC
CureVac
$5.36
+0.4%
$5.42
$2.37
$5.72
$1.20B2.53461,819 shs365,200 shs
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$1.08
+12.8%
$0.67
$0.39
$3.38
$22.32M1.992.42 million shs425,883 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CureVac N.V. stock logo
CVAC
CureVac
+0.37%+0.19%-2.19%-2.55%+55.81%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
+12.79%+18.05%+110.53%+116.87%+66.10%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CureVac N.V. stock logo
CVAC
CureVac
$5.36
+0.4%
$5.42
$2.37
$5.72
$1.20B2.53461,819 shs365,200 shs
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$1.08
+12.8%
$0.67
$0.39
$3.38
$22.32M1.992.42 million shs425,883 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CureVac N.V. stock logo
CVAC
CureVac
+0.37%+0.19%-2.19%-2.55%+55.81%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
+12.79%+18.05%+110.53%+116.87%+66.10%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CureVac N.V. stock logo
CVAC
CureVac
2.20
Hold$6.8327.49% Upside
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest HTCR and CVAC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2025
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHoldStrong-Buy
6/26/2025
CureVac N.V. stock logo
CVAC
CureVac
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyNeutral$12.00 ➝ $5.50
(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CureVac N.V. stock logo
CVAC
CureVac
$579.18M2.08$0.88 per share6.12$3.36 per share1.60
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
$30.41M0.83$0.82 per share1.32$0.17 per share6.35
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CureVac N.V. stock logo
CVAC
CureVac
$175.50M$0.965.58N/AN/A38.21%29.57%25.41%11/11/2025 (Estimated)
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
-$1.48M-$0.01N/A6.75N/A-0.62%141.93%46.22%11/13/2025 (Estimated)

Latest HTCR and CVAC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/21/2025Q2 2025
CureVac N.V. stock logo
CVAC
CureVac
-$0.15-$0.30-$0.15-$0.30$4.27 million$1.41 million
8/13/2025Q2 2025
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
-$0.08$0.04+$0.12$0.04$5.27 million$4.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CureVac N.V. stock logo
CVAC
CureVac
N/AN/AN/AN/AN/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CureVac N.V. stock logo
CVAC
CureVac
0.05
6.17
6.16
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
0.52
1.26
1.26

Institutional Ownership

CompanyInstitutional Ownership
CureVac N.V. stock logo
CVAC
CureVac
17.26%
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
1.71%

Insider Ownership

CompanyInsider Ownership
CureVac N.V. stock logo
CVAC
CureVac
N/A
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
57.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
CureVac N.V. stock logo
CVAC
CureVac
880224.34 millionN/AOptionable
HeartCore Enterprises, Inc. stock logo
HTCR
HeartCore Enterprises
4023.31 million9.93 millionNot Optionable

Recent News About These Companies

HeartCore Posts Profit in Fiscal Q2
HeartCore Signs 16th Go IPO Contract

New MarketBeat Followers Over Time

Media Sentiment Over Time

CureVac stock logo

CureVac NASDAQ:CVAC

$5.36 +0.02 (+0.37%)
Closing price 09/15/2025 04:00 PM Eastern
Extended Trading
$5.36 0.00 (0.00%)
As of 04:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

HeartCore Enterprises stock logo

HeartCore Enterprises NASDAQ:HTCR

$1.08 +0.12 (+12.79%)
Closing price 09/15/2025 04:00 PM Eastern
Extended Trading
$1.06 -0.02 (-1.39%)
As of 04:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HeartCore Enterprises, Inc., a software development company, provides Software as a Service solutions to enterprise customers in Japan and internationally. Its customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. The company also operates a digital transformation business that offers customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises. In addition, it provides consulting services; and education, services, and support solutions. The company was founded in 2009 and is headquartered in Tokyo, Japan.